No photo of Roman Perez-Soler

View Scopus Profile

Roman Perez-Soler, M.D.

  • 10678 Citations
  • 50 h-Index
1980 …2018

Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 14 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Liposomes Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Cisplatin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
Platinum Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1991 1999

ANTHRACYCLINES WITH HIGH AFFINITY FOR LIPID MEMBRANES

Perez-Soler, R.

National Institutes of Health

1/1/91 → 12/31/99

Project: Research project › Research Project

Anthracyclines
Membrane Lipids
Doxorubicin
Anti-Bacterial Agents
Membranes

Publications 1980 2018

2 Citations

Leptomeningeal metastases in non-small-cell lung cancer

Cheng, H. & Perez-Soler, R. Jan 1 2018 In : The Lancet Oncology. 19, 1, p. e43-e55

Research output: Contribution to journal › Review article

Non-Small Cell Lung Carcinoma
Neoplasm Metastasis
Cerebrospinal Fluid
Therapeutics
Cell Biology

Mouse models in squamous cell lung cancer: impact for drug discovery

Singh, A. P., Adrianzen Herrera, D., Zhang, Y., Perez-Soler, R. & Cheng, H. Apr 3 2018 In : Expert Opinion on Drug Discovery. 13, 4, p. 347-358 12 p.

Research output: Contribution to journal › Review article

Squamous Cell Neoplasms
Drug Discovery
Heterografts
Lung Neoplasms
Animal Models

Wide expression and significance of alternative immune checkpoint molecules, B7x and HHLA2, in PD-L1–negative human lung cancers

Cheng, H., Borczuk, A., Janakiram, M., Ren, X., Lin, J., Assal, A., Halmos, B., Perez-Soler, R. & Zang, X. Apr 15 2018 In : Clinical Cancer Research. 24, 8, p. 1954-1964 11 p.

Research output: Contribution to journal › Article

Lung Neoplasms
Non-Small Cell Lung Carcinoma
Neoplasms
T-Lymphocytes
Immunotherapy
3 Citations

18F-Fluorodeoxyglucose/Positron Emission Tomography Predicts Patterns of Failure After Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer

Ohri, N., Bodner, W. R., Halmos, B., Cheng, H., Perez-Soler, R., Keller, S. M., Kalnicki, S. & Garg, M. Feb 1 2017 In : International Journal of Radiation Oncology Biology Physics. 97, 2, p. 372-380 9 p.

Research output: Contribution to journal › Article

Fluorodeoxyglucose F18
Non-Small Cell Lung Carcinoma
Positron-Emission Tomography
lungs
lesions
7 Citations

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): An open-label, multicentre, randomised, phase 3 trial

Wakelee, H. A. , Dahlberg, S. E. , Keller, S. M. , Tester, W. J. , Gandara, D. R. , Graziano, S. L. , Adjei, A. A. , Leighl, N. B. , Aisner, S. C. , Rothman, J. M. , Patel, J. D. , Sborov, M. D. , McDermott, S. R. , Perez-Soler, R. , Traynor, A. M. , Butts, C. , Evans, T. , Shafqat, A. , Chapman, A. E. , Kasbari, S. S. & 3 others Horn, L., Ramalingam, S. S. & Schiller, J. H. 2017 (Accepted/In press) In : The Lancet Oncology.

Research output: Contribution to journal › Article

Adjuvant Chemotherapy
Non-Small Cell Lung Carcinoma
Drug Therapy
docetaxel
gemcitabine